Microsoft’s Copilot Faces Adoption Challenges
Microsoft is struggling to sell its Copilot AI assistant to corporations because many employees are opting for OpenAI’s ChatGPT instead. This unexpected preference is creating challenges for Microsoft, which has invested heavily in its AI technology.
Last spring, drugmaker Amgen Inc. announced plans to purchase Microsoft’s Copilot for 20,000 employees. Microsoft highlighted this deal in three separate case studies as a testament to its AI capabilities. However, thirteen months later, it was discovered that Amgen employees were actually using ChatGPT, a rival product developed by OpenAI.
This unexpected turn of events is causing concerns for Microsoft, which has made significant investments in its AI technology. The company’s partnership with OpenAI, the developer of ChatGPT, is also being put to the test as the two companies navigate the competitive landscape of AI assistants in the corporate world.
The preference for ChatGPT over Copilot among corporate employees raises questions about Microsoft’s strategy for its AI assistant. As the demand for AI technology continues to grow, Microsoft will need to address the concerns of its corporate clients and find ways to make its Copilot more appealing to employees.
